EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma

Quigly Dragotakes, Patrick W Johnson, Matthew R Buras, Rickey E Carter iD, Michael J Joyner iD, Evan Bloch, Kelly A Gebo, Daniel F Hanley, Jeffrey P Henderson iD, Liise-Anne Pirofski, Shmuel Shoham iD, Jonathon W Senefeld und 6 weitere

Proceedings of the National Academy of Sciences · 08.10.2024 · 121 (41)

DOI: 10.1073/pnas.2414957121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024-10. Verfasst von Quigly Dragotakes und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, MD 21205. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Serotherapy, Immunization, Passive, SARS-CoV-2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the Spring of 2020, the United States of America (USA) deployed COVID-19 convalescent plasma (CCP) to treat hospitalized patients. Over 500,000 patients were treated with CCP during the first year of the pandemic. In this study, we estimated the number of actual inpatient lives saved by CCP treatment in the United States of America based on CCP weekly use, weekly national mortality data, and CCP mortality reduction data from meta-analyses of randomized controlled trials and real-world data. We also estimate the potential number of lives saved if CCP had been deployed for 100% of hospitalized patients or used in 15 to 75% of outpatients. Depending on the assumptions modeled in stratified analyses, we estimated that CCP saved between 16,476 and 66,296 lives. The CCP ideal use might have saved as many as 234,869 lives and prevented 1,136,133 hospitalizations. CCP deployment was a successful strategy for ameliorating the impact of the COVID-19 pandemic in the USA. This experience has important implications for convalescent plasma use in future infectious disease emergencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 SerotherapyImmunization, PassiveSARS-CoV-2HumansUnited StatesHospitalizationPandemics

Stichwörter der Autor:innen

COVID-19SARS-CoV-2antibodyconvalescent plasmamortality

Autor:innen und Institutionen

  • Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, MD 21205.
  • Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, FL 32224.
  • Division of Biostatistics and Clinical Trials, Department of Quantitative Health Sciences, Scottsdale, AZ 85259.
  • Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL 32224.
  • Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN 55905.
  • Department of Pathology, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD 21205.

ORCID-Profile: Rickey E Carter, Michael J Joyner, Jeffrey P Henderson, Shmuel Shoham, David J Sullivan, Arturo Casadevall

Förderung

  • NIAID NIH HHS

Zitieren

APA

Dragotakes, Q., Johnson, P. W., Buras, M. R., Carter, R. E., Joyner, M. J., Bloch, E., Gebo, K. A., Hanley, D. F., Henderson, J. P., Pirofski, L. A., Shoham, S., Senefeld, J. W., Tobian, A. A. R., Wiggins, C. C., Wright, R. S., Paneth, N. S., Sullivan, D. J., & Casadevall, A. (2024). Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma. Proceedings of the National Academy of Sciences, 121(41). https://doi.org/10.1073/pnas.2414957121

Vancouver

Dragotakes Q, Johnson PW, Buras MR, Carter RE, Joyner MJ, Bloch E, et al. Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma. Proceedings of the National Academy of Sciences. 2024;121(41). doi:10.1073/pnas.2414957121

BibTeX
@article{Dragotakes2024,
  author = {Dragotakes, Quigly and Johnson, Patrick W and Buras, Matthew R and Carter, Rickey E and Joyner, Michael J and Bloch, Evan and Gebo, Kelly A and Hanley, Daniel F and Henderson, Jeffrey P and Pirofski, Liise-Anne and Shoham, Shmuel and Senefeld, Jonathon W and Tobian, Aaron A R and Wiggins, Chad C and Wright, R Scott and Paneth, Nigel S and Sullivan, David J and Casadevall, Arturo},
  title = {Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {41},
  doi = {10.1073/pnas.2414957121}
}
Kostenlos starten →